Prevest Denpro (PREVEST) | Stock Overview & Key Data
Prevest Denpro Performance Comparison
Stock Range
Today's Range
Low: ₹540.10
High: ₹559.90
on October 3, 2025
52 Week Range
Low: ₹393.60
High: ₹686.00
on March 17, 2025
on January 13, 2025
All-Time High: ₹686.00 on January 13, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR6.7B
EPS
15.86
P/E Ratio (TTM)
34.49
Forward P/E
N/A
P/B Ratio
6.22
PEG Ratio
1.73
Div. Yield
0.17%
ROE
17.20%
Beta
0.431
Debt to Equity
0.00
Financial Highlights
Profitability
Gross Margin
77.43%
Operating Margin
30.58%
Profit Margin
28.86%
Returns and Earnings
Return on Assets (TTM)
16.13%
Return on Equity (TTM)
17.20%
EBITDA
INR272.5M
Net Income (TTM)
INR188.9M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR54.52
Quarterly Revenue Growth (YoY)
18.10%
Quarterly Earnings Growth (YoY)
19.90%
Dividend Information
Last 12-Month Dividend
₹1.00
Current Dividend Yield
0.17%
3-Year Average Dividend Yield
0.17%
3-Year Average Annual Dividend
₹0.33
3-Year Total Dividends
₹1.00
Ex-Dividend Date
September 3, 2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Prevest Denpro PREVEST | 6.65B Small-cap | -1.01% | -6.44% | -2.72% | 7.46% | -9.26% | -8.64% | 33.44% | 105.45% |
| Poly Medicure POLYMED | 193.74B Mid-cap | -2.49% | -7.56% | -14.74% | -15.41% | -28.70% | -18.60% | 89.07% | 301.81% |
| Dr Agarwal's Health AGARWALEYE | 157.95B Mid-cap | 2.21% | 18.47% | 21.34% | 14.60% | 24.39% | 24.26% | 24.26% | 24.26% |
| Laxmi Dental LAXMIDENTL | 18.40B Small-cap | 4.09% | -1.01% | -25.20% | -20.95% | -40.09% | -35.84% | -35.84% | -35.84% |
| Tarsons Products TARSONS | 16.33B Small-cap | -1.41% | -4.86% | -22.88% | -13.85% | -24.76% | -30.54% | -61.55% | -62.71% |
| Shree Pacetronix SHREEPAC | 823.22M Small-cap | 3.89% | 28.97% | 134.14% | 225.08% | 77.11% | 44.31% | 261.94% | 1,770.00% |
Ownership & Short Interest
Insider Ownership
78.37%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
3K
Average 90-Day Volume
8K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is PREVEST's 52-week high and low?
- In the last 52 weeks, Prevest Denpro reached a high of ₹686.00 (on January 13, 2025) and a low of ₹393.60 (on March 17, 2025).
- What is the market cap and P/E ratio for PREVEST?
- Curious about Prevest Denpro's size and valuation? Its market capitalization stands at 6.65B. When it comes to valuation, the P/E ratio (trailing twelve months) is 34.49, and the forward P/E (looking ahead) is N/A.
- Does PREVEST pay dividends? If so, what's the yield?
- Yes, Prevest Denpro is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.17%, and the company has paid an average of ₹0.33 per share annually over the past 3 years.
- Who are Prevest Denpro's main competitors or similar companies to consider before investing?
When looking at Prevest Denpro, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Poly Medicure
POLYMED193.74B Healthcare Medical Instruments & Supplies -18.60% 89.07% Dr Agarwal's Health
AGARWALEYE157.95B Healthcare Medical Instruments & Supplies 24.26% 24.26% Laxmi Dental
LAXMIDENTL18.40B Healthcare Medical Instruments & Supplies -35.84% -35.84% Tarsons Products
TARSONS16.33B Healthcare Medical Instruments & Supplies -30.54% -61.55% Shree Pacetronix
SHREEPAC823.22M Healthcare Medical Instruments & Supplies 44.31% 261.94% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Prevest Denpro Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Prevest Denpro's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 17.20%, the Debt to Equity ratio from the most recent quarter is 0.00, and its Gross Profit Margin stands at 77.43%.
- What is the recent revenue and earnings growth for PREVEST?
- Looking at Prevest Denpro's growth, its revenue over the trailing twelve months (TTM) was INR654M. Compared to the same quarter last year (YoY), quarterly revenue grew by 18.10%, and quarterly earnings saw a YoY growth of 19.90%.
- How much of PREVEST stock is held by insiders and institutions?
- Wondering who owns Prevest Denpro stock? Company insiders (like executives and directors) hold about 78.37% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.